ClinConnect ClinConnect Logo
Search / Trial NCT07009873

Clinical Application of Wearable Ultrasound Sensors

Launched by CHINESE PLA GENERAL HOSPITAL · Jun 6, 2025

Trial Information

Current as of August 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new wearable ultrasound sensor designed to help doctors diagnose and monitor conditions like Deep Vein Thrombosis (DVT) and heart problems more easily and in real-time. The goal is to create a device that patients can wear, which allows for quick and accurate imaging of their health conditions without needing to visit a hospital for tests. This innovative technology could change how we manage various diseases by making monitoring more convenient and efficient.

To participate in this trial, you need to be at least 18 years old and able to give your consent. You'll also need to have a relevant health condition, such as heart failure or confirmed lower-limb DVT, or be in an intensive care unit (ICU) where constant monitoring is needed. If you qualify, you can expect to wear the device for monitoring, which will help researchers understand how well it works. However, certain factors, like skin infections or difficulties in cooperation, may prevent you from joining the study. This trial is currently not recruiting participants, but it represents an exciting step forward in improving patient care through technology.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 yrs and able to consent
  • Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)
  • Adequate acoustic window and intact skin at sensor site
  • Arm-specific:
  • Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy
  • DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention
  • ICU arm: ICU/post-op patient requiring continuous bedside ultrasound
  • Exclusion Criteria:
  • Poor acoustic window preventing interpretable images
  • Local skin infection, open wound, or implant/hardware blocking sensor
  • Inability to cooperate with monitoring
  • Arm-specific:
  • Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months
  • DVT arm: Active bleeding or severe coagulopathy
  • ICU arm: Unstable multi-organ failure precluding safe monitoring

About Chinese Pla General Hospital

The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yukun Luo, Professor, M.D.

Principal Investigator

Chinese PLA General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported